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SUMMARY.
1. Experiments are described in which the determination of the course of
metabolism of 3:4 benzpyrene in mouse skin has been followed both quanti-
tatively and qualitatively over periods of up to 24 hours.
2. The only metabolic product discovered was BPX2.
3. There is an initial time lag of approximately 1 hour before any metabolite
can be found.
4. Once metabolism commences there is a fairly rapid build-up of the meta-
bolite.
5. This build-up reaches a peak value, and then there is a slow decline in the
amount present.
6. The meaning and significance of these findings is discussed.
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ALTHOUGH the fact is now well established that the incidence and latent
period of tumours induc6d by 3:4-benzpyrene depend to some extent on the
solvent employed, a proper understanding ofthis " solvent effect " is still lacking.
This is partly due to the complex nature of the natural oils and fats most fre-
quently used in studies on solvent effects. Their action is the resultant of a
multiplicity of component effects which may be either synergistic or antagonistic.
Progress is more likely to come from a study ofsimple synthetic or near-synthetic
solvent systems which are more amenable to interpretation in terms of bio-
chemical reactions or properties.
The idea that the pro- or anticarcinogenic effects of solvents might be
correlated with differences in the elimination rate of benzpyrene was first formu-
lated by Peacock and Beck (1938) who, on the basis of qualitative visual inspec-
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tion, attributed the anticarcinogenic effect of certain solvents to the faster
disappearance of benzpyrene from the injection site. A systematic analysis in
which an accurate method for the quantitative estimation of benzpyrene was
used failed to establish a clear-cut correlation in the case of some natural lipids,
i.e. cod liver oil, mouse fat and their hydrogenation products (Weil-Malherbe
and Dickens, 1944; Dickens and Weil-Malherbe, 1946). Likewise, Rusch,
Mueller and Kline (1945) could not find any obvious relationship between the
rate of elimination of benzpyrene and the solvent effect. On the other hand,
Weil-Malherbe and Dickens (1946), when investigating the effects of tricaprylin
solutions of cholesterol and phospholipids, obtained the unexpected result that
the more rapid elimination of benzpyrene was associated with the higher carcino-
genic activity and the slower elimination with lower carcinogenic activity.
That a correlation was obtained at all was probably due to the comparative
simplicity of the solvent systems used, but confirmatory evidence is clearly
desirable before the results can be generalized. It was with this object in view
that a study ofthe effects of a number of different compounds on the elimination
rate of benzpyrene was undertaken.
MATERIALS AND METHODS.
Phospholipids.-Phospholipids were prepared from ox brain by the method
previously described (Weil-Malherbe and Dickens, 1946), with the difference
that the preparation was done on a larger scale, 2300 g. of brain being used as
starting material. The alcohol-soluble (lecithin) fraction weighed 22-5 g. and
contained 3-12 per' cent P and 2-50 per cent N, whereas 24 g. of the alcohol-
insoluble (kephalin) fraction contained 3-78 per cent P and 2-34 per cent N.
Both fractions were kept in sealed ampoules under nitrogen. The high N-content
and, in the case of lecithin, the low P-content indicate that the fractions were
still very impure.
Other compounds.-The following preparations were carried out:
Perbenzoic acid (Organic Syntheses, 1933). A 15 per cent solution in tri-
caprylin was prepared and kept in the refrigerator. The solution wus standard-
ized iodometrically before use.
Tricaprylin (Hartwell, 1940). M.P. 8-5-10-5°.
Ethyl linoleate (Organic Syntheses, 1942).
Ascorbyl palmitate (Swern, Stirton, Turer and Wells, 1943). M.P. 1150.
0-1756 g. used 7 80 ml. 0-1 N iodine solution.
Cholestanol (Organic Syntheses, 1937). M.P. 1410. Liebermann-Burchard
reaction negative.
7-Dehydrocholesterol (Windaus, Lettre and Schenck, 1935; Rosenberg,
1941). M.P. 1430.
Ergosterol peroxide (Windaus and Brunken, 1928). M.P. 1740.
All melting points are uncorrected.
Coprostanol, epi-coprostanol and epi-cholestanol were supplied by Dr. H.
King, F.R.S., National Institute for Medical Research.
Other chemicals used were commercial products of various origin.
Benzpyrene was estimated as previously described (Weil-Malherbe, 1944;
Dickens and Weil-Malherbe, 1946).
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1. Oxidation of 3:4-Benzpyrene in vitro.
It has been suggested (Weil-Malherbe and Dickens, 1946) that the retardation
ofbenzpyrene elimination and the delay oftumour formation caused by phospho-
lipids might be cortnected with their antioxidant properties. It was, however,
realized from the beginning that antioxidant activity in the accepted sense
cannot be expected to occur in the living animal cell. Antioxidant activity
probably consists in the breaking of reaction chains initiated by autoxidation
processes (e.g. Filer, Mattil and Longenecker, 1944). The existence in the
reduced form ofautoxidizable substances, such as ascorbic acid, thiol compounds,
etc., in the living cell is symptomatic of the absence of widespread autoxidation
processes, and reaction chains of any considerable length are unlikely to occur
in the complex medium of the cell. It is therefore not surprising that Rusch,
Mueller and Kline (1945) failed to find any correlation between the autoxidizabilitv
of a solvent and its effect on carcinogenesis.
On the other hand, carcinogenic hydrocarbons, such as 20-methylcholanthrene
(Simpson and Cramer, 1945) or 3:4-benzpyrene (Weigert and Mottram, 1946)
seem to be oxidized as soon as they permeate into the interior of almost any
living cells with which they come into contact. Their oxidation is therefore
more likely to be incidental to the normal metabolic aetivities of the cell than to
the action of a specific enzyme. Such a mechanism might involve a peroxide
or a radical of high oxidant potential with or without the intervention of a
peroxidase. Such an induced oxidation might be inhibited by phospholipids or
other antioxidants owing to their higher affinity for the oxidant.
It was therefore felt that useful information might perhaps be gathered
from a study of the oxidation of benzpyrene in vitro and the action of various
antioxidants and c9mbinations of antioxidants thereon.
TABLE 1.-Oxidation of Benzpyrene by Hydrogen Peroxide in 80 per cent
Acetic Acid.
Each tube contained 1 mg. benzpyrene in 10 ml. 80 per cent acetic
acid. After addition of 0-2 ml. 30 per cent hydrogen peroxide the tubes
were left at room temperature for 16 hours.
Percentage of
benzpyrene present
Additions. at end of
experiment.
0 . . . . . . . . . . 88-6
200 mg. lecithin . . . . . . . . 56-4
200 ,, kephalin . . . . . . . . 56 4
200 ,, lecithin + 1 mg. ascorbic acid . . . . 57.5
200 ,, ,, + 1 ,, c-tocopherol (Roche) . . . 65-2
200 ,, ,, + 1 ,, ascorbic acid + 1 mg. oc-tocopherol . 60-8
As shown by Table I, benzpyrene is slowly oxidized by a solution of 0-6 per
cent hydrogen peroxide in 80 per cent acetic acid. In this system both lecithin
and kephalin had a powerful pro-oxidant effect which was little modified bv
their combination with other antioxidants.
An effect in the opposite direction was found when the oxidation of benz-
pyrene was carried out in a lipoid medium. In these experiments a solution of
412LIPOID SOLVENTS AND 3:4-BENZPYRENE
perbenzoic acid in tricaprylin was added to a tricaprylin solution of benzpyrene
(Table II). Here the addition of lecithin resulted in a marked inhibition of the
oxidation, which was still further enhanced by combination with oc-tocopherol, but
wasreduced by combination with ascorbic acid or carotene. Almostthe maximum
potentiation effect is observed with a concentration of 01 mg. tocopherol in
2 ml. (Table III). Cholesterol was found to have an effect similar to, though
much smaller than, that of lecithin (Table IV). This effect is somewhat accen-
tuated by carotene, but reduced by ascorbic acid.
TABLE II.-Oxidation of Benzpyrene by Perbenzoic Acid in Tricaprylin.
Each.tube contained 1 mg. benzpyrene in 15 ml. tricaprylin. After
addition of 0 5 ml. of a 12 per cent solution of perbenzoic acid in tri-
caprylin the tubes were sealed undernitrogen andleft at room temperature
for 70 hours in the dark. *
Additions.
0
30 mg.
30
30
30 ,,
3
30
30 ,,
en+it.hin
+ 0 5 mg. oc-tocopherol (Roche)
±,+0 5 ,, ascorbic acid .
+ 0 5 ,, oc-tocopherol + 0 5 mg. ascorbic acid
5-carotene (Roche)
lecithin + 3 mg. 5-carotene
+ 3 ,, ,, -+ 0 5 mg. oc-tocopherol
Percentage
of unchanged
benzpyrene.
14*9
45-5
52*2
31-4
33*8
15* 1
26-8
28*2
TABLE 111.-Effect of Combination of Lecithin with Varying Amounts of
oc-Tocopherol on Oxidation ofB6nzpyrene by Perbenzoic Acid.
Arrangement as in preceding experiment (Table II).
Percentage
Additions. of unchanged
benzpyrene.
30 mg. lecithin . . . . . . . 31-2
30 ,, ,, + 0 Ing. c-tocopherol . . 47-5
30 ,, ,, +1 ,, ,, . . 55-0
30 ,, + 10 ,, ,, . . 55-5
TABLE IV.-Effect of Cholesterol on Oxidation of Benzpyrene by
Perbenzoic Acid.
Each tube contained 1 mg. benzpyrene in 1-5 ml. tricaprylin. After
addition of 0-25 ml. of a 5 per cent solution of perbenzoic acid in tri-
caprylin the tubes were sealed under nitrogen and left at room tempera-.
ture for 48 hours in the dark.
Additions.
0 .
30 mg. cholesterol
30 , ,
30 ,,
+ 3 mg. carotene
+ 3 ,, ascorbic acid
Percentage
of unchanged
benzpyrene.
33-8
48-1
56-0
41 9
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At the time these experiments were performed it was not known that the
effects of the new phospholipid samples differed from those of the earlier sample
in experiments in vivo. The fact that cholesterol and phospholipids had similar
effects in vitro and seemingly opposite ones in vivo suggested that the model
systems did not approximate closely enough to in vivo conditions. The experi-
ments were therefore discontinued; they do show, however, that the oxidation
of benzpyrene may be affected by other substances present in concentrations
which were previously shown to be effective in experiments in vivo.
II. The Effect of Lipoid Solvents on the Rate of Elimination of
3:4-Benzpyrene after Subcutaneous Injection in Mice.
Whereas their antioxidant properties were thought to be responsible for the
effects ofphospholipids on the elimination rate and carcinogenicity ofbenzpyrene,
it was also tentatively suggested that the opposite effects of cholesterol might
be connected with the well-known propensity of sterols and steroids to form
coordination compounds. By investigating a number of substances belonging
to the two classes of antioxidants and sterols as to their effect on the elimination
rate of benzpyrene, it was hoped to obtain further evidence by which the reality
of the proposed mechanisms miight be examined. Since synergistic effects are
not uncommon when two or more antioxidants are present together (Mattill,
1945) various such combinations were tried.
The substances to be tested were dissolved in tricaprylin containing 01 per
cent benzpyrene and injected into batches of 5-10 mice. After an interval of
4-5 weeks the mice were killed and the remainder of benzpyrene estimated.
Since it has been shown by ourselves (Dickens and Weil-Malherbe, 1946; Weil-
Malherbe and Dickens, 1946) and others (Berenblum and Schoental, 1942) that
the elimination of benzpyrene follows roughly the course of a monomolecular
reaction, the reaction constant may be determined from a single observation.
A period of 4-5 weeks was found to give the most favourable results, as the
benzpyrene level has decreased to a significant extent, but is usually still suffi-
ciently high to allow of accurate measurement.
Male mice of the Cxlaxo FF strain were used. Each mouse received 0 3 mg.
benzpyrene, dissolved in 0 3 ml., subcutaneously into the left axillary region.
The animals were examined in ultraviolet light for leakage of fluorescent material
immediately after the injection and thereafter several times weekly, and all
those showing signs of leakage or ulceration were rejected. Ulceration was
only observed with a few of the solutions, most of them being well tolerated.
Tricaprylin solutions containing 0-6 mg. of 5-carotene (Roche) proved
extremely toxic for mice after subcutaneous injection, leading to the death of
13 out of 16 animals after 2-5 days. No mention of this high toxicity of sub-
cutaneously administered 5-carotene for mice could be found in the literature.
Sexton, Mehl and Deuel (1946) injected 0 3 mg. carotene in oil intravenously,
and up to 1.1 mg. intraperitoneally, into rats, apparently without ill-effects.
Chauchard (1941) reported that intraperitoneal injection- of carotene has a
depressant action on nervous response in rats, guinea-pigs and rabbits.
Results.-The monomolecular reaction constants were calculated according
to the formula k =
I log S where t = days after injection, a = initial and
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S = final quantity of benzpyrene. The mean value of k and the standard error
of the mean were calculated for each batch. The figures are assembled in
Tables V and VI. A series of 24 analyses on mice injected with benzpyrene
solutions in pure tricaprylin were carried out to provide a standard of com-
parison. The mean of k was found to be 0-0154 ± 0-00132, a value in excollent
agreement with that previously obtained (Weil-Malherbe and Dickens, 1946).
The mean k-value of each experiment was compared with the mean k-value
of the standard series and the difference was tested for statistical sianificance.
It appears from Table V that out of all the antioxidants and combinations of
antioxidants tested only one had a delaying effect of probable significance on
benzpyrene elimination, viz. ascorbyl palmitate in a concentration of 2 per
cent. No effect was observed with the same substance in a concentration of
0'5 per cent. Unfortunately ascorbyl palmitate caused ulceration in a number
TABLE V.--Elimination ofBenzpyrenefrom Solutions Containing Antioxidants and
Related Substances after Subcutaneow Injection into Mice.
C:oncentration
Addition (%)
in tricaprylin.
Lecithin
Kephalin
o.-Tocopherol
Ascorbyl palmitate
Ethyl linoleato
Ethvl chloro-
phyllide
2-Methyl-3:4-
naphthoquinone
f-Carotene
Lecithin (3%) + oc-tocopherol
(0*3%)
Kephalin (3%,') + oc-tocopherol (1I/)
Cholesterol (3%) + ox-tocopherol
(1%) . .
Lecithin (3%) + ascorbyl palmitate
(0*5%) . .
Lecithin (3%) + ascorbyl palmitate
' (0
-5%) + o.-tocopherol (0.3%) .
p-Carotene (0-2%) + ascorbyl pal-
mitate (0.3°%)
Total
number
of
animals.
8
5
5
5
7
9
5
6
k
(mean).
0 0242
0*0251
0*0291
0 0442
0*0148
0.0091
0 0132
0*0251
Standard
error.
0*00228
0*00588
0*0056
0 0107
0 00295
0*0028
0*0023
0 0071
5 . 0-0218 . 0-00464
3
2
4
5
0-0272
0 0132
* <0.01
0 02
<0'01
<0.01
n.s.
0 03
n.s.
0 03
n.s.
0 0043
0*0373 . 0*00106 . <0*01
0-0431 . 0*00563 . <0X01
5 . 0*0287
5 . 0X0104
4 . 0 0152
0 00436 . <0'01
0*00231
0 00251
n.s.
n.s.
1 . 0 0096
3
3
0 3
1
0 5 (ulc.)
2
3
100
0 3
0 3 (ulc.)
0 2
* P = probability value obtained by testing the significance of the difference between mean
values of k for a particular solvent and for standard series ofpure tricaprylin. n.s. = not significant.
ulc. experiment in which some ulceration occurred (mice showing ulceration are not included
in the results).
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of cases. The other substances tested either had no effect on the rate of elimina-
tion or accelerated it. Surprisingly, both lecithin and kephalin were found to
increase the rate of elimination in these experiments, in contrast to the earlier
result (Weil-Malherbe and Dickens, 1946). On the whole, the reproducibility
of results was found to be quite satisfactory, as shown by the k-values obtained
for pure tricaprylin or for cholesterol, cholestanol or ascorbyl palmitate solutions
in different experiments. The discrepancy in the case of the phospholipids
must be attributed to real differences in the two preparations, both of which
were rather crude. a-Tocopherol, in 03 per cent and still more in 1 per cent
concentration, brought about a very pronounced acceleration of benzpyrene
elimination which was little affected by the presence of lecithin, kephalin or
cholesterol. Generally, no synergistic effects were observed with mixtures of
antioxidants, but ascorbyl palmitate reduced to normal level the increase caused
by lecithin or by lecithin + oc-tocopherol.
Ethyl linoleate is included in Table V as an example of ain autoxidizable
lipid. At a concentration of 3 per cent in tricaprylin solution it had no effect
on benzpyrene elimination. Pure ethyl linoleate as solvent for benzpyrene
caused a slight, but probably significant acceleration. The mean k-value found
in this series is, however, below the values calculated from the figures of Rusch,
Mueller and Kline (1945), but the figures of these authors are generally higher
than any found in this laboratory with lipoid solvents, ever since the factor of
leakage and ulceration was adequately controlled. The difference may be partly
accounted for by the practice of Rusch et al. of excising the tissues surrounding
TABLE VI.-Elimination of Benzpyrene from Solutions Containing Sterols and
Related Substances after Subcutaneous Injection into Mice.
Concentration Total
Addition (%) number k Standard
k of (mean). error. P.*
in tricaprylin. animals.
Cholesterol . . 3 . 6 . 0 0337 . 0 0068 . <0.01
Cholestanol . . 3 . 5 . 0-0348 . 0 0026 . <0.01
10 . 5 . 0-0283 . 0-0020 . <0.01
epi-Cholestanol . . 3 (ulc.) . 3 . 0-0178 . 0 0085 . n.s.
Coprostanol . . 3 . 5 . 0-0116 . 0-0020 . n.s,
epi-Coprostanol. . 3 . 6 . 0'0155 . 0-0022 . n.s.
Sitosterol (Roche) . 3 . 5 . 0'0253 . 0 0057 . 0 02
"Phytosterol " (L.
Light & Co.) 3 . 5 . 00112 . 0-0028 . n.s.
Ergosterol. . . 3 . 5 . 0-0136 . 0 0037 . n.s.
7-Dehydrocholesterol. 3 . 5 . 00100 . 0 0017 . n.s.
Ergosterol peroxide . 2 . 12 . 0-0174 . 0-0044 . n.s.
Calciferol . . . 0-2 . 6 . 0-0231 . 0 00737 . n.s.
Deoxycholic acid . 1 (sus- . 5 . 0-0221 . 0-0044 . n.s.
pension)
* P = probability value obtained by testing the significance of the difference between mean
values of k for a particular solvent and for standard series of pure tricaprylin. n.s. = not signi-
ficant.
ulc. = experiment in which some ulceration occurred (mice showing ulceration are not included
in rc<ults).
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the injection area for analysis, a procedure which involves the risk of loss of
injected material.
Table VI contains the results obtained with a number of sterols. In agree-
ment with the previous result (Weil-Malherbe and Dickens, 1946) cholesterol
was found to accelerate the elimination rate. The only sterol with a comparable
effect was cholestanol. An acceleration of probable significance was also
observed with sitosterol (Roche). None of the other compounds tested altered
the rate of elimination significantly.
III. Experiments on the Correlation of Elimination Rate
and Carcinogenicity of 3:4-Benzpyrene.
It was one of the objects of the survey described in the preceding section-to
find substances which would affect the elimination rate of benzpyrene in a
positive or negative sense, and to test whether the change could be correlated
with an inhibition or stimulation of tumour induction. In view of the dis-
crepancy of the results obtained with the two different preparations of phospho-
lipids their use seemed undesirable, as it indicated an insufficient control of all
variables. There remained the choice between tocopherol and cholestanol as
accelerators of benzpyrene elimination. The effect of tocopherol on tumour
induction has already been studied by Rusch, Mueller and Kline (1945). The
use of cholestanol therefore recommended itself. It was employed as a 3 per
cent solution in tricaprylin.
The only substance with a probable inhibitory action on benzpyrene elimina-
tion was ascorbyl palmitate in 2 per cent solution. This was used for a second
series of injections, although it was liable to cause ulceration.
A third series of mice was injected with benzpyrene in pure tricaprylin as a
standard of comparison and as a check on the reproducibility of earlier results.
Glaxo FF mice of both sexes were used for the experiment. Groups of 55
mice were injected subcutaneously with the three different solvents, each animal
receiving 03 ml. benzpyrene in 03 ml. solvent. One mouse of each series was
sacrificed weekly for the analysis ofits benzpyrene content.
Ulceration occurred in more than half of the mice injected with the solution
of ascorbyl palmitate. None of the mice thus affected has been included in the
final analysis, although two of them subsequently developed local tumours.
Benzpyrene estimations on ulcer mice showed that the bulk of the injected
benzpyrene was usually lost when ulceration occurred.
TABLE VIL.-Tumour Incidence after 45 Weeks.
Effectual Number % Number of
Solvent. total - mice alive p.* Solvent. of of local and tumour-
mice. tumours. free.
30,h Cholestanol in tri-
caprylin . . . 31 . 23 74 3
Tricaprylin . . . 36 . 14 39 11 o 1
2% Ascorbyl palmitate in
tricaprylin . . . 17 . 7 41 . 5 .
* P = probability ofdifference being due to chance obtained by applying %2-test.
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Tumour incidence.-The relevant data are contained in Table VII and
Fig. 1. Whereas the curves for the tricaprylin and ascorbyl palmitate series
are almost identical, the tumour incidence is increased in the cholestanol series.
The difference between the cholestanol and tricaprylin series was evaluated by
80 _
70
60
;50
-
g30 -;
140
0 10 20 30 40
Weeks
FIG. 1.-Incidence of local tumours following subcutaneous injection of 0 3 mg. 3:4-benz-
pyrene in the following solvents: (A) 3 per cent cholestanol in tricaprylin (solid circles);
(B) tricaprylin (rings)-; (c) 2 per cent ascorbyl palmitate in tricaprylin (crosses).
the X2-test and was found to be statistically significant. The percentage incidence
found in the tricaprylin series is in good agreement with the figures obtained in
previous experiments (Weil-Malherbe and Dickens, 1944; 1946; Dickens and
Weil-Malherbe, 1946). The latent period was about the same in all three series.
TABLE VIII.-Elimination Constants of Benzpyrene in Different Solvents.
Number of Linear
Solvent. observa- regression Standard p*
tions. coefficient. error.
3% Cholestanol in tri-
caprylin . . 14
Tricaprylin . . 16
2% Ascorbyl palmitate
in tricaprylin . . 8
-0-0371
-0-0222
-0- 00564 .
0-00469 1
0-00482
0-00162
<0-05>0-02
<0.01
* P probability value obtained by testing the. significance of the difference between two re-
gression coefficients.
Eilimination of 3:4-benzpyrene.-The logarithms of S - the amount of
benzpyrene remaining after t days have been plotted in Fig. 2 for the three series
418LIPOID SOLVENTS AND 3:4BENZPYRENE
of solvents used. The straight lines represent the linegr regression curves
calculated by the method of least squares. Their numerical values are given in
Table VIII together with their standard error. Owing to the large proportion
of ulceration in the ascorbyl palmitate experiment the number of animals was
insufficient to continue the analyses for more than 50 days. Later, some
analyses were carried out on mice which had developed tumours. The values of
benzpyrene found at this time were, however, far below those which might
have been expected if the elimination curve had continued linearly. It must
1 %Ns~~~~~~~~~~%
-05 -
:t_ ~ .3
0~~~~~
20 \
-0-5~~~~~~
*10 20 30 40 50 60 70 80 90 100 110 120 130
Days
FIG[. 2.-Rate of elimination of 3:4-benzpyrene after subcutaneous injection in the following
solvents:(A) 3 per cent cholestanol in tricaprylin (dotted line; solid circles); (iB) tri-
caprylin (line of dots and da-shes; rings); (a) 2 per cent ascorbyl palmitate in tricaprylin
(full line; solid.squares. The broken line indicates the assumed elimination rate in the
second phase. Bracketed squares represent analyses in which no measurable amounts of
benzpyrene were detected).
be assumed that a change in the elimination rate had taken place in the interval.
These late values were therefore not included in the calculation of the regression
coefficient. The same tendency towards an accelerated elimination in the final
phases of the elimination process can be discerned in the two other series,
especially in the tricaprylin experiment. The 'inclusion of these late values is
probably responsible for the fact that the constant was found to be somewhat
higher than in previous experiments, though the difference is not significant.
Statistical analysis showed that the difference between the regression coeffi-
cients for the ascorbyl palmitate and the tricaprylin experiments was significant,
that between the constants of the tricaprvvlin and the cholestanol experiment
probably significant.
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DISCUSSION.
In confirmation of previous results (Weil-Malherbe and Dickens, 1946) it
has been found that the higher rate of benzpyrene elimination in the cholestanol
series was also associated with a higher incidence of induced tumours. This
correlation is further strengthened by the results of Rusch, Mueller and Kline
(1945) on the effect of tocopherol. These authors found a stimulating effect on
tumour induction by small amounts of tocopherol (0-1-0-2 mg.) in some experi-
ments, though not regularly. As reported in this paper, 3 mg. tocopherol has
a very pronounced accelerating effect on the rate of benzpyrene elimination.
With 0-9 mg. the effect is still significant, though less intense. It would be
interesting to investigate whether the procarcinogenic effect of tocopherol would
be more regular if higher doses than those employed by Rusch et al. were used.
On the other hand, ascorbyl palmitate did not influence the incidence of
tumours, although it inhibited the elimination of benzpyrene for a limited period.
The results of benzpyrene analyses in this series seem to show that after 7-8
weeks the inhibition is followed by an activation of elimination. The latter
phenomenon may cancel out any effects caused by the former, and the negative
result obtained in this experiment is therefore not necessarily inconsistent
with a correlation between low rate of elimination and low incidence of tumours.
The initial protection of benzpyrene by ascorbyl palmitate may be explained
by the assumption of a higher affinity of the latter substance for the oxidant
resulting in its preferential oxidation. The product of oxidation which is
possibly a peroxide may itself catalyze the subsequent oxidation of benzpyrene.
A similar process, though it is presumably much faster, may underlie the induced
oxidation of benzpyrene in 80 per cent acetone containing autoxidizing ascorbic
acid (Warren, 1943).
The effects of a number of sterols on the elimination of benzpyrene allow
some tentative conclusions as to the mechanism of the activation caused bv
some of them.
A possibility which had to be considered was a pro-oxidant mechanism
similar to that assumed for the oxidation product of ascorbyl palmitate. Though
a cholesterol peroxide is not known, other sterols, such as ergosterol or 7-dehydro-
cholesterol, areknownto form peroxides, and a metabolic conversion of cholesterol
to 7-dehydrocholesterol is quite feasible. However, not only the parent sub-
stances, ergosterol and 7-dehydrocholesterol, but also ergosterol peroxide itself
were quite inactive.
Ifthe structure of active and inactive sterols is considered as in the following
comparison-
Active sterols. Inactive sterols.
Cholestanol Epi-cholestanol
Cholesterol Coprostanol
(Sitosterol) Epi-coprostanol
"Phytosterol " (probably mainly
stigmasterol)
7-Dehydrocholesterol
Ergosterol
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it appears that the active substances have a trans 1:I11-, cis C3:C10-configuration
and not more than one double bond. Substances with trans C3:C10- (epi-
cholestanol) or with cis I:I1-configuration (coprostanol) or with both (epi-copro-
stanol) as well as substances with more than one double bond (stigmasterol,
7-dehydrocholesterol and ergosterol) are inactive. This is exactly the situation
found bv Davis, Krahl and Clowes (1940) in their investigation on the interaction
of benzpyrene and sterols in surface films. Their results indicate the formation
of association complexes between benzpyrene and cholesterol or cholestanol at
a water-air interface, whereas interaction is weak or absent with epi-cholestanol,
coprostanol and ergosterol. The authors assumed that the hydrocarbon molecule
is held between two appropriately oriented sterol molecules. The special steric
configuration of cholestanol and cholesterol was thought to be more favourable
to optimum packing of the molecules than the steric configuration ofthe inactive
sterols.
This analogy is probably more than a mere coincidence. The association
between sterol and hydrocarbon might decrease the hydrophobic properties and
increase the surface activity of the hydrocarbon and thus account for-its higher
reactivity. The accelerated rate of elimination of benzpyrene probably indicates
a more rapid metabolism ofthis substance, but it is still open to question whether
this process is actually involved in the etiology of the cancerous change. The
formation of association complexes between benzpyrene and sterols may at the
same time lead to an easier accessibility ofthe oxidant and to a freer deployment
of the forces or reactions responsible for carcinogenesis. Whether the two
processes are linked or independent cannot be decided at present. A clear-cut
correlation ofdelayed elimination with anticarcinogenesis would be more valuable
evidence in this respect.
Deoxycholic acid, in spite of its eminent capacity for the formation of co-
ordination compounds, increases the rate of elimination only slightly. This
may be due to the low solubility of deoxycholic acid in tricaprylin. From an
aqueous solution of benzpyrene and sodium deoxycholate the hydrocarbon is
eliminated at a greatly increased rate (Weil-Malherbe, 1947).
SUMMARY.
(1) In experiments on the in vitro oxidation of 3:4-benzpyrene it is shown
that addition of other substances may result in either a pro- or anti-oxidant
effect according to the conditions. Thus phospholipids greatly increase the
rate of oxidation of 3:4-benzpyrene by hydrogen peroxide in 80 per cent acetic
acid, whereas lecithin alone or, to a greater extent, in combination with oc-toco-
pherol inhibits the oxidation of benzpyrene by perbenzoic acid in tricaprylin
solution. Addition of cholesterol has a similar, though smaller, effect.
(2) Mice were injected subcutaneously with tricaprylin solutions of 3:4-
benzpyrene containing one or more of a number of additional compounds and
the effect of these additions on the rate of benzpyrene elimination was studied.
The substances tested mainly belonged to the two classes of antioxidants and
sterols. The earlier observation of a delaying effect of phospholipids could not
be confirmed with a new sample; on the contrary, the new sample of phospho-
lipids accelerated the elimination of benzpyrene. Otherwise the reproducibility
ofresults, as far as it was tested, was satisfactory.
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Ascorbyl palmitate in 2 per cent but not in 0 5 per cent solution was the
only substance with a probable inhibitory effect, whereas oc-tocopherol caused a
marked acceleration. Amongst sterols, cholesterol, cholestanol and sitosterol
increased the rate of elimination. Attention is drawn to the capacity of these
sterols of forming association complexes with 3:4-benzpyrene in surface films
and to the inactivity in this respect of those sterols which do not affect the rate
of elimination of benzpyrene.
(3) The higher rate of benzpyrene elimination brought about by cholestanol
(3 per cent solution in tricaprylin) is associated with a higher incidence of local
sarcomas. The delay of benzpyrene elimination in the presence of ascorbyl
palmitate (2 per cent solution in tricaprylin) is only temporary and lasts for
about 6-7 weeks. It is probably followed by a phase of accelerated elimination.
The addition of ascorbyl palmitate did not affect the incidence of induced
tumours.
Grateful acknowledgment is made for the supply of samples of coprostanol,
epi-coprostanol and epi-cholestanol by Dr. 0. Rosenheim, F.R.S., and Dr. H.
King, F.R.S., and for histological examinations by Dr. R. Schade.
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